Free Trial

Arch Therapeutics (ARTH) Short Interest Ratio & Short Volume

Arch Therapeutics logo
$0.16 0.00 (0.00%)
As of 06/1/2026

Arch Therapeutics Short Interest Overview

As of April 15, 2025, Arch Therapeutics (ARTH) had a short interest of 6,600 shares sold short, representing 0.15% of the public float. This marks a -55.70% decrease in short interest since the prior report. The short interest ratio (days to cover) is 0.6, meaning it would take 0.6 days of the average trading volume of 4,068 shares to cover all short positions.

Current Short Interest
6,600 shares
Previous Short Interest
14,900 shares
Change Vs. Previous Month
-55.70%
Dollar Volume Sold Short
$1.32 thousand
Short Interest Ratio
0.6 Days to Cover
Last Record Date
April 15, 2025
Outstanding Shares
4,742,000 shares
Short Percent of Float
0.15%
Today's Trading Volume
0 shares
Average Trading Volume
4,068 shares
Today's Volume Vs. Average
0%
Short Selling Arch Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Arch Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

ARTH Short Interest Over Time

ARTH Days to Cover Over Time

ARTH Percentage of Float Shorted Over Time

Arch Therapeutics Tesla Short Interest History & Recent Changes

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/20256,600 shares $1.32 thousand -55.7%0.1%0.6 $0.20
3/31/202514,900 shares $2.86 thousand +22.1%0.3%8.3 $0.19
3/15/202512,200 shares $2.63 thousand -0.8%0.3%24.4 $0.22
2/28/202512,300 shares $2.86 thousand +2.5%0.3%1.7 $0.23
2/15/202512,000 shares $2.67 thousand -0.8%0.3%3.9 $0.22
1/31/202512,100 shares $2.19 thousand +0.8%N/A1.1 $0.18
1/15/202512,000 shares $2.04 thousand -3.2%N/A3.9 $0.17
12/31/202412,400 shares $2.11 thousand -0.8%N/A0.8 $0.17
12/15/202412,500 shares $3.07 thousand +0.8%N/A0.4 $0.25
11/30/202412,400 shares $2.65 thousand -6.1%N/A1.4 $0.21
11/15/202413,200 shares $3.42 thousand -9.6%N/A0.9 $0.26
10/31/202414,600 shares $4.57 thousand +16.8%N/A0.8 $0.31
10/15/202412,500 shares $3.38 thousand -28.2%N/A0.4 $0.27
9/30/202417,400 shares $10.61 thousand +40.3%N/A0.6 $0.61
9/15/202412,400 shares $9.30 thousand No ChangeN/A4 $0.75
8/31/202412,400 shares $6.97 thousand No ChangeN/A2.5 $0.56
8/15/202412,400 shares $8.18 thousand -3.9%N/A3.4 $0.66
7/31/202412,900 shares $9.42 thousand +2.4%N/A5.4 $0.73
7/15/202412,600 shares $7.87 thousand -0.8%N/A2.3 $0.62
6/30/202412,700 shares $10.87 thousand -5.2%N/A2.9 $0.86
6/15/202413,400 shares $14.67 thousand No ChangeN/A2.5 $1.10
5/31/202413,400 shares $15.14 thousand No ChangeN/A3.9 $1.13
5/15/202413,400 shares $13.94 thousand +8.1%N/A2.7 $1.04
4/30/202412,400 shares $14.63 thousand -5.3%N/A2.9 $1.18
4/15/202413,100 shares $14.80 thousand +5.7%N/A2 $1.13
3/31/202412,400 shares $24.30 thousand No ChangeN/A3.2 $1.96
3/15/202412,400 shares $26.04 thousand No ChangeN/A2.1 $2.10
2/29/202412,400 shares $33.48 thousand -1.6%N/A1 $2.70
2/15/202412,600 shares $37.80 thousand -41.4%N/A1.5 $3.00
1/15/202431,300 shares $167.46 thousand No ChangeN/A1.4 $5.35
12/31/202331,300 shares $226.61 thousand +3.6%N/A0.5 $7.24
12/15/202330,200 shares $138.92 thousand +1.3%N/A0.3 $4.60
11/30/202329,800 shares $178.80 thousand +52.8%N/A0.3 $6.00
11/15/202319,500 shares $39 thousand +828.6%N/A0.7 $2.00
10/31/20232,100 shares $2.00 thousand No ChangeN/A0.8 $0.95
10/15/20232,100 shares $1.26 thousand No ChangeN/A0.3 $0.60
9/30/20232,100 shares $2.73 thousand -43.2%N/A0.6 $1.30
9/15/20233,700 shares $9.62 thousand +76.2%N/A0.3 $2.60
8/31/20232,100 shares $3.09 thousand -4.6%N/A1.3 $1.47
8/15/20232,200 shares $3.50 thousand -12.0%N/A0.5 $1.59
"You'll own nothing and be happy" (it's not a theory anymore) (Ad)

On May 3rd, 2025, Warren Buffett looked at his shareholders for the last time and said: "The dollar is going to hell." Ray Dalio agrees. The founder of Bridgewater Associates ($150 billion AUM) calls it a "debt death spiral." But there's a specific asset class and investment system that actually thrives when the dollar collapses.tc pixel

Watch how to protect yourself from what Dalio and Buffett see coming (free training).
7/31/20232,500 shares $5.18 thousand +13.6%N/A1.8 $2.07
7/15/20232,200 shares $6.27 thousand +144.4%N/A5.5 $2.85
6/30/2023900 shares $2.70 thousand +800.0%N/A0.8 $3.00
6/15/2023100 shares $325.00 No ChangeN/A0.1 $3.25
5/15/2023200 shares $550.00 +100.0%N/A0.2 $2.75
4/30/2023100 shares $275.00 -80.0%N/A0.1 $2.75
4/15/2023500 shares $1.65 thousand +66.7%N/A0.2 $3.30
3/31/2023300 shares $1.05 thousand -40.0%N/A0.1 $3.50
3/15/2023500 shares $1.95 thousand No ChangeN/A0.4 $3.90
2/28/2023500 shares $1.75 thousand No ChangeN/A0.3 $3.50
1/15/20239,300 shares $322.71 No ChangeN/A0.1 $0.03
11/30/202219,700 shares $886.50 +579.3%N/A0.1 $0.05
11/15/20222,900 shares $145.00 +16.0%N/A0 $0.05
10/31/20222,500 shares $116.00 -99.0%N/A0 $0.05
10/15/2022243,200 shares $9.73 thousand +2,332.0%N/A0.2 $0.04
9/30/202210,000 shares $192.00 +108.3%N/A0 $0.02
9/15/20224,800 shares $76.80 No ChangeN/A0 $0.02
8/15/2022500 shares $20.50 No ChangeN/A0 $0.04
7/15/20224,100 shares $180.40 No ChangeN/A0 $0.04
6/15/202235,100 shares $1.76 thousand No ChangeN/A0.1 $0.05
5/15/20224,000 shares $320.00 No ChangeN/A0 $0.08
4/15/202216,100 shares $1.43 thousand +1,912.5%N/A0.1 $0.09
3/31/2022800 shares $78.08 -46.7%N/A0 $0.10
3/15/20221,500 shares $141.00 +275.0%N/A0 $0.09
2/28/2022400 shares $39.96 -98.7%N/A0 $0.10
2/15/202230,800 shares $2.99 thousand No ChangeN/A0.1 $0.10
1/15/202281,000 shares $8.40 thousand +16.2%N/A0.3 $0.10
12/31/202169,700 shares $6.62 thousand -74.0%N/A0.1 $0.10
12/15/2021268,000 shares $31.89 thousand +53,500.0%N/A0.3 $0.12
11/30/2021500 shares $49.30 +150.0%N/A0 $0.10
11/15/2021200 shares $22.00 -99.6%N/A0 $0.11
10/29/202151,100 shares $6.06 thousand +132.3%N/A0.1 $0.12
10/15/202122,000 shares $2.38 thousand -63.0%N/A0 $0.11
9/30/202159,500 shares $7.74 thousand -43.7%N/A0.2 $0.13
9/15/2021105,600 shares $10.30 thousand +345.6%N/A0.1 $0.10
8/31/202123,700 shares $1.62 thousand -86.4%N/A0 $0.07
8/13/2021173,800 shares $16.04 thousand -6.9%N/A0.2 $0.09
7/30/2021186,600 shares $16.79 thousand -3.1%N/A0.4 $0.09
7/15/2021192,600 shares $17.33 thousand +11.9%N/A0.3 $0.09
6/30/2021172,100 shares $16.32 thousand -9.1%N/A0.2 $0.09
6/15/2021189,400 shares $18.48 thousand -18.0%N/A0.2 $0.10

ARTH Short Interest - Frequently Asked Questions

Short interest is the volume of Arch Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 6,600 shares of ARTH short. 0.15% of Arch Therapeutics' shares are currently sold short. Learn More on Arch Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ARTH shares currently have a short interest ratio of 0.6. Learn More on Arch Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.15% of Arch Therapeutics' floating shares are currently sold short.

Arch Therapeutics saw a decline in short interest during the month of April. As of April 15th, there was short interest totaling 6,600 shares, a decline of 55.7% from the previous total of 14,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.15% of Arch Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Arch Therapeutics: Dalton Industries Inc. (0.00%), Nuwellis, Inc. (1.34%), Autonomix Medical, Inc. (3.01%), Valion Bio, Inc. Common Stock (7.43%), INVO Fertility, Inc (7.68%), Vycor Medical, Inc. (0.04%), Catheter Precision, Inc. (0.72%), Bone Biologics Corp. (0.17%), Pheton Holdings Ltd (0.38%), Bluejay Diagnostics, Inc. (0.65%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Inc ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management Inc. ($3.86 billion), Capital One Financial Corporation ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Corporation ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks.

Short selling ARTH is an investing strategy that aims to generate trading profit from Arch Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Arch Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ARTH, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ARTH, twice per month. The most recent reporting period available is April, 15 2025.

Understanding short interest metrics can help you assess how traders are positioning around a stock like ARTH:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



This page (OTCMKTS:ARTH) was last updated on 6/2/2026 by MarketBeat.com Staff.
From Our Partners